{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T07:28:45Z","timestamp":1793258925012,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T00:00:00Z","timestamp":1753920000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["2017003"],"award-info":[{"award-number":["2017003"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Guangdong Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2024A1515013289"],"award-info":[{"award-number":["2024A1515013289"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370383"],"award-info":[{"award-number":["82370383"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82400343"],"award-info":[{"award-number":["82400343"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.hrthm.2025.07.051","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T21:15:56Z","timestamp":1754428556000},"page":"e1086-e1096","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Left atrial appendage closure vs oral anticoagulation for stroke prevention in atrial fibrillation: Long-term outcomes from 4 randomized trials"],"prefix":"10.1016","volume":"22","author":[{"given":"Wulamiding","family":"Kaisaier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjuan","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yugang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1280-0158","authenticated-orcid":false,"given":"Wengen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrthm.2025.07.051_bib1","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.hrthm.2025.07.051_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.07.051_bib3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/europace\/euaa365","article-title":"Long-term oral anticoagulant after catheter ablation for atrial fibrillation","volume":"23","author":"Chew","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.051_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.119.007612","article-title":"Outcomes and anticoagulation use after catheter ablation for atrial fibrillation","volume":"12","author":"Freeman","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib5","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1253\/circj.CJ-19-0602","article-title":"Current status and clinical outcomes of oral anticoagulant discontinuation after ablation for atrial fibrillation in Japan - findings from the AF frontier ablation registry","volume":"83","author":"Okumura","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.hrthm.2025.07.051_bib6","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1093\/eurheartj\/ehr393","article-title":"Left atrial appendage closure: a percutaneous transcatheter approach for stroke prevention in atrial fibrillation","volume":"33","author":"Landmesser","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.07.051_bib7","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2025.07.051_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib9","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.07.051_bib10","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1001\/jama.2014.15192","article-title":"Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial","volume":"312","author":"Reddy","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.hrthm.2025.07.051_bib11","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.hrthm.2025.07.051_bib13","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2021.10.023","article-title":"4-year outcomes after left atrial appendage closure versus nonwarfarin oral anticoagulation for atrial fibrillation","volume":"79","author":"Osmancik","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2023.1212161","article-title":"Efficacy and safety of left atrial appendage closure compared with oral anticoagulation in atrial fibrillation: a meta-analysis of randomized controlled trials and propensity-matched studies","volume":"10","author":"Franchin","year":"2023","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.hrthm.2025.07.051_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.034815","article-title":"Left atrial appendage closure compared with oral anticoagulants for patients with atrial fibrillation: a systematic review and network meta-analysis","volume":"13","author":"Oliva","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hrthm.2025.07.051_bib17","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1016\/j.jacc.2020.08.089","article-title":"Left atrial appendage closure versus oral anticoagulants in atrial fibrillation: a meta-analysis of randomized trials","volume":"76","author":"Turagam","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib18","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1056\/NEJMoa2408308","article-title":"Left atrial appendage closure after ablation for atrial fibrillation","volume":"392","author":"Wazni","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrthm.2025.07.051_bib19","author":"Higgins"},{"key":"10.1016\/j.hrthm.2025.07.051_bib20","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.07.051_bib21","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.07.051_bib22","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/j.hrthm.2025.07.051_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.carrev.2021.04.019","article-title":"Left atrial appendage closure versus oral anticoagulation in non-valvular atrial fibrillation: a systematic review and meta-analysis","volume":"36","author":"Al-Abcha","year":"2022","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.hrthm.2025.07.051_bib24","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/CIRCEP.115.002993","article-title":"Left atrial appendage occlusion device and novel oral anticoagulants versus warfarin for stroke prevention in nonvalvular atrial fibrillation: systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Briceno","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib25","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.amjcard.2023.05.044","article-title":"An updated meta-analysis on the clinical outcomes of percutaneous left atrial appendage closure versus direct oral anticoagulation in patients with atrial fibrillation","volume":"200","author":"Jiang","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib26","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12928-022-00839-1","article-title":"Latest outcomes of transcatheter left atrial appendage closure devices and direct oral anticoagulant therapy in patients with atrial fibrillation over the past 5 years: a systematic review and meta-analysis","volume":"37","author":"Takeda","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.hrthm.2025.07.051_bib27","article-title":"Comparison of the efficacy and safety of left atrial appendage closure and direct oral anticoagulants for atrial fibrillation: a meta-analysis of randomized control trials and observational studies","volume":"15","author":"Wei","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.hrthm.2025.07.051_bib28","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1016\/j.jacc.2019.09.064","article-title":"Long-term safety and efficacy in continued access left atrial appendage closure registries","volume":"74","author":"Holmes","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib29","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR left atrial appendage occlusion registry","volume":"75","author":"Freeman","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib30","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial","volume":"143","author":"Kar","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.hrthm.2025.07.051_bib31","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013750","article-title":"Outcomes with the WATCHMAN FLX in everyday clinical practice from the NCDR left atrial appendage occlusion registry","volume":"17","author":"Kapadia","year":"2024","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2025.07.051_bib32","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.hrthm.2024.07.028","article-title":"Impact of early bleeding on long-term mortality after left atrial appendage occlusion","volume":"22","author":"Lo Russo","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.07.051_bib33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2025.07.051_bib34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1378\/chest.10-0134","article-title":"A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey","volume":"138","author":"Pisters","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.hrthm.2025.07.051_bib35","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.07.051_bib36","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/europace\/euz258","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update","volume":"22","author":"Glikson","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.hrthm.2025.07.051_bib37","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.amjcard.2017.03.253","article-title":"Changes in coagulation and platelet activation markers following transcatheter left atrial appendage closure","volume":"120","author":"Rod\u00e9s-Cabau","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jacc.2023.09.831","article-title":"Antithrombotic therapy for patients undergoing cardiac electrophysiological and interventional procedures: JACC state-of-the-art review","volume":"83","author":"Di Biase","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib39","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.hrthm.2017.05.038","article-title":"Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-year follow-up outcome data of the EWOLUTION trial","volume":"14","author":"Boersma","year":"2017","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.07.051_bib40","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jacep.2015.04.006","article-title":"Left atrial appendage ligation and ablation for persistent atrial fibrillation: the LAALA-AF registry","volume":"1","author":"Lakkireddy","year":"2015","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib41","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/14779072.2018.1510316","article-title":"Antithrombotic strategies after interventional left atrial appendage closure: an update","volume":"16","author":"Chen","year":"2018","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.hrthm.2025.07.051_bib42","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","article-title":"Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion","volume":"14","author":"Della Rocca","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2025.07.051_bib43","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.119.008481","article-title":"Reduced rivaroxaban dose versus dual antiplatelet therapy after left atrial appendage closure: ADRIFT a randomized pilot study","volume":"13","author":"Duthoit","year":"2020","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2025.07.051_bib44","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.hrthm.2024.11.035","article-title":"Reduced direct oral anticoagulant dose vs dual antiplatelet therapy after left atrial appendage closure in patients with nonvalvular atrial fibrillation: a systematic review and meta-analysis","volume":"22","author":"Lima","year":"2025","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.07.051_bib46","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jacep.2023.10.012","article-title":"Severity of ischemic stroke after left atrial appendage closure vs nonwarfarin oral anticoagulants","volume":"10","author":"Turagam","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib47","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1016\/j.hrthm.2024.05.030","article-title":"Ischemic stroke severity and mortality after left atrial appendage closure vs nonwarfarin oral anticoagulants in patients with prior stroke","volume":"21","author":"Turagam","year":"2024","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hrthm.2025.07.051_bib48","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1016\/j.jacc.2015.09.084","article-title":"Time to cost-effectiveness following stroke reduction strategies in AF: warfarin versus NOACs versus LAA closure","volume":"66","author":"Reddy","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib49","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1080\/13696998.2023.2266275","article-title":"Cost-effectiveness of left atrial appendage closure with Watchman for non-valvular atrial fibrillation patients in Japan","volume":"26","author":"Kamae","year":"2023","journal-title":"J Med Econ"},{"key":"10.1016\/j.hrthm.2025.07.051_bib50","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ahj.2020.08.008","article-title":"Cost-effectiveness of combined catheter ablation and left atrial appendage closure for symptomatic atrial fibrillation in patients with high stroke and bleeding risk","volume":"231","author":"Kawakami","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.hrthm.2025.07.051_bib51","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1093\/eurheartj\/ehab847","article-title":"Cost-effectiveness analysis of left atrial appendage occlusion in patients with atrial fibrillation and contraindication to oral anticoagulation","volume":"43","author":"Labori","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hrthm.2025.07.051_bib52","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12962-023-00486-0","article-title":"Cost-effectiveness of left atrial appendage closure for stroke prevention in atrial fibrillation: a systematic review appraising the methodological quality","volume":"21","author":"Hewage","year":"2023","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/j.hrthm.2025.07.051_bib53","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/j.jcin.2023.01.011","article-title":"SCAI\/HRS expert consensus statement on transcatheter left atrial appendage closure","volume":"16","author":"Saw","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.hrthm.2025.07.051_bib54","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.jacc.2013.03.035","article-title":"Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology)","volume":"61","author":"Reddy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hrthm.2025.07.051_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2025.04.029","article-title":"Comparison of left atrial appendage closure and oral anti-coagulation after catheter ablation for atrial fibrillation: concomitant and sequential cohorts of the OPTION randomized controlled trial","author":"Saliba","year":"2025","journal-title":"Heart Rhythm Forthcoming"}],"container-title":["Heart Rhythm"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125027328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1547527125027328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:03:04Z","timestamp":1778868184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1547527125027328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":54,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S1547527125027328"],"URL":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.07.051","relation":{},"ISSN":["1547-5271"],"issn-type":[{"value":"1547-5271","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left atrial appendage closure vs oral anticoagulation for stroke prevention in atrial fibrillation: Long-term outcomes from 4 randomized trials","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrthm.2025.07.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Heart Rhythm Society.","name":"copyright","label":"Copyright"}]}}